FORCONI FRANCESCO

Attività di ricerca

Ultime pubblicazioni:

  • Ravandi, F., Kreitman, R.J., Tiacci, E., Andritsos, L., Banerji, V., Barrientos, J.C., et al. (2022). Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. BLOOD CANCER JOURNAL, 12(12), 165 [10.1038/s41408-022-00760-z]. - dettaglio
  • Moia, R., Dondolin, R., De Propris, M.S., Talotta, D., Mouhssine, S., Perutelli, F., et al. (2022). Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. HEMATOLOGICAL ONCOLOGY [10.1002/hon.3080]. - dettaglio
  • Andritsos, L.A., Anghelina, M., Neal, J., Blachly, J.S., Mathur, P., Lele, O., et al. (2022). Development of a distributed international patient data registry for hairy cell leukemia. LEUKEMIA & LYMPHOMA, 63(13), 3021-3031 [10.1080/10428194.2022.2109157]. - dettaglio
  • Grever, M., Andritsos, L., Banerji, V., Barrientos, J.C., Bhat, S., Blachly, J.S., et al. (2021). Hairy cell leukemia and COVID-19 adaptation of treatment guidelines. LEUKEMIA, 35(7), 1864-1872 [10.1038/s41375-021-01257-7]. - dettaglio
  • Dahal, L.N., Dou, L., Hussain, K., Liu, R., Earley, A., Cox, K.L., et al. (2017). STING activation reverses lymphoma-mediated resistance to antibody immunotherapy. CANCER RESEARCH, canres.2784.2016 [10.1158/0008-5472.CAN-16-2784]. - dettaglio